WallStreetZenWallStreetZen

NASDAQ: MRVI
Maravai Lifesciences Holdings Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Maravai Lifesciences Holdings revenue was $259.19M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $56.4M, down 13.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MRVI annual revenue was $259.2M, with -10.3% growth year-over-year.

MRVI past revenue growth

How has MRVI's revenue growth performed historically?

Company
-10.3%
Industry
511.06%
Market
20.87%
MRVI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MRVI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MRVI's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MRVI revenue history

Current Revenue
$259.2M
Current Earnings
-$144.8M
Current Profit Margin
-55.9%

Be the first to know when MRVI announces revenue.

MRVI Revenue History By Year

MRVI Yearly RevenueMRVI RevenueMRVI ChangeMRVI Revenue Growth
2024-12-31$259.19M-$29.76M-10.30%
2023-12-31$288.95M-$594.06M-67.28%
2022-12-31$883.00M$83.76M+10.48%
2021-12-31$799.24M$515.14M+181.33%
2020-12-31$284.10M$140.96M+98.48%
2019-12-31$143.14M$19.31M+15.59%
2018-12-31$123.83MN/AN/A

1 of 1

Maravai Lifesciences Holdings Revenue FAQ

What was MRVI's revenue last quarter?

On Invalid Date, Maravai Lifesciences Holdings (NASDAQ: MRVI) reported Q4 2024 revenue of $56.41 million up 23.92% year over year. In the same quarter last year, Maravai Lifesciences Holdings's revenue was $74.14 million.

What was Maravai Lifesciences Holdings's revenue in 2024?

Maravai Lifesciences Holdings's annual revenue for the twelve months ending Dec 31, 2024 was $259.19 million, a 10.3% decrease year over year.

How much does Maravai Lifesciences Holdings make in a day?

Based on Maravai Lifesciences Holdings annual revenue for the past five years, MRVI makes an average of $1,377,791.23 per day.

What was Maravai Lifesciences Holdings's annual revenue growth in the past year?

As of Q2 2025, Maravai Lifesciences Holdings's revenue has grown -10.3% year over year. This is 521.36 percentage points lower than the US Biotechnology industry revenue growth rate of 511.06%. Maravai Lifesciences Holdings's revenue in the past year totaled $259.19 million.

How much does Maravai Lifesciences Holdings make in a year?

Maravai Lifesciences Holdings's revenue by year for the past five years is:
  • Maravai Lifesciences Holdings's revenue for the twelve months ending Dec 31, 2024 was $259.19 million, a 10.3% decrease year over year.
  • Maravai Lifesciences Holdings's annual revenue for Dec 31, 2023 was $288.95 million, a 67.28% decrease from 2022.
  • Maravai Lifesciences Holdings's annual revenue for 2022 was $883.00 million, a 10.48% increase from 2021.
  • Maravai Lifesciences Holdings's annual revenue for 2021 was $799.24 million, a 181.33% increase from 2020.
  • Maravai Lifesciences Holdings's annual revenue for 2020 was $284.10 million, a 98.48% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.